Phase 1 study of IMGN853, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC) in patients (Pts) with epithelial ovarian cancer (EOC) and other FRA-positive solid tumors.-Reference-Cited by-同舟云学术

Phase 1 study of IMGN853, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC) in patients (Pts) with epithelial ovarian cancer (EOC) and other FRA-positive solid tumors.

Published:2015-05-20 Issue:15_suppl Volume:33 Page:5558-5558
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Borghaei Hossein¹,O'Malley David M.²,Seward Shelly Marie³,Bauer Todd Michael⁴,Perez Raymond P.⁵,Oza Amit M.⁶,Jeong Woondong⁷,Michenzie Mary F.⁸,Kirby Maurice William⁹,Chandorkar Gurudatt¹⁰,Ruiz-Soto Rodrigo¹⁰,Birrer Michael J.¹¹,Moore Kathleen N.¹²

Affiliation:

1. Fox Chase Cancer Center, Philadelphia, PA

2. The Ohio State University College of Medicine, Columbus, OH

3. Wayne State Univ- Karmanos Cancer Inst, Huntington Woods, MI

4. Sarah Cannon Research Institute / Tennessee Oncology, PLLC., Nashville, TN

5. University of Kansas, Fairway, KS

6. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

7. Westchester Hem/Onc Grp, Westchester, NY

8. ImmunoGen Inc, Dedham, MA

9. ImmunoGen Inc, Waltham, MA

10. Immunogen, Waltham, MA

11. Massachusetts General Hospital/Dana Farber Cancer Center, Boston, MA

12. University of Oklahoma Health Sciences Center, Oklahoma City, OK

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2015.33.15_suppl.5558

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability;Cancers;2023-01-24

2. Targeted therapy and molecular genetics;DiSaia and Creasman Clinical Gynecologic Oncology;2023

3. Antibody-drug Conjugate Targets, Drugs, and Linkers;Current Cancer Drug Targets;2022-07

4. In vivo safety testing of Antibody Drug Conjugates;Regulatory Toxicology and Pharmacology;2021-06

5. Immunotherapy Advances for Epithelial Ovarian Cancer;Cancers;2020-12-11